KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Debt Ratio (2017 - 2025)

Historic Debt Ratio for Aquestive Therapeutics (AQST) over the last 9 years, with Q3 2025 value amounting to 0.22.

  • Aquestive Therapeutics' Debt Ratio fell 2204.84% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year decrease of 2204.84%. This contributed to the annual value of 0.32 for FY2024, which is 3311.45% down from last year.
  • Latest data reveals that Aquestive Therapeutics reported Debt Ratio of 0.22 as of Q3 2025, which was down 2204.84% from 0.37 recorded in Q2 2025.
  • Aquestive Therapeutics' Debt Ratio's 5-year high stood at 1.02 during Q3 2022, with a 5-year trough of 0.22 in Q3 2025.
  • Over the past 5 years, Aquestive Therapeutics' median Debt Ratio value was 0.61 (recorded in 2021), while the average stood at 0.58.
  • Its Debt Ratio has fluctuated over the past 5 years, first soared by 6491.33% in 2022, then plummeted by 6787.42% in 2024.
  • Quarter analysis of 5 years shows Aquestive Therapeutics' Debt Ratio stood at 0.86 in 2021, then rose by 5.73% to 0.91 in 2022, then plummeted by 47.53% to 0.48 in 2023, then plummeted by 33.11% to 0.32 in 2024, then crashed by 30.86% to 0.22 in 2025.
  • Its Debt Ratio was 0.22 in Q3 2025, compared to 0.37 in Q2 2025 and 0.33 in Q1 2025.